Coronavirus: Indonesia approves Sinopharm vaccine for emergency use; Thailand says latest wave has peaked

Published Apr 30 2021 at 10:18 AM GMT
  • Indonesia’s drug regulator on Friday approved the Covid-19 vaccine of China’s Sinopharm, which it will use in a private immunisation scheme where companies buy government-procured vaccines to inoculate their staff.
  • After Sinovac Biotech and AstraZeneca, Sinopharm is the third company to have its vaccine approved by Indonesia, which is seeking to inoculate 181.5 million people by January 2022.
  • It has suffered one of the worst Covid-19 outbreaks in Asia, with 1 66 million infections and more than….



  • Published Apr 30, 2021 10:18 AM GMT